SCHEMBL23220190

SCHEMBL23220190

CC(C)C(C)N(C)C(=O)OCc1ccc(N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.42
TPSAB1 Q15661 3/20 0.40
PRSS1 P07477 2/20 0.40
ITGB1 P05556 2/20 0.39
ITGA5 P08648 2/20 0.39
ITGB3 P05106 1/20 0.39
ITGAV P06756 1/20 0.39
PHLPP2 Q6ZVD8 1/20 0.38
LMNA P02545 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAOA P21397 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25100442 0.84 ABCB1 (0.53) ABCB1KMT2AALDH1A1HPGDMAPK1
SCHEMBL21697889 0.84 TPSAB1 (0.40) ABCB1TPSAB1PRSS1ITGB1ITGA5
SCHEMBL25859740 0.84 TPSAB1 (0.40) ABCB1TPSAB1PRSS1ITGB1ITGA5
SCHEMBL21952369 0.84 ABCB1 (0.44) ABCB1TPSAB1PRSS1ITGB1ITGA5
SCHEMBL25100408 0.83 ABCB1 (0.39) ABCB1TPSAB1PRSS1ITGB1ITGA5
SCHEMBL20435506 0.79 PRSS1 (0.44) ABCB1TPSAB1PRSS1PHLPP2LMNA
SCHEMBL20434505 0.79 TPSAB1 (0.46) ABCB1TPSAB1PRSS1ITGB1ITGA5
SCHEMBL24040106 0.78 CTSB (0.40) ABCB1TPSAB1PRSS1ITGB1ITGA5
SCHEMBL7369869 0.77 ABCB1 (0.50) ABCB1LMNAMEN1KMT2AALDH1A1
SCHEMBL21896174 0.76 PRSS1 (0.49) ABCB1TPSAB1PRSS1PHLPP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10973920-B2 Saccharide derivative of a toxic payload and antibody conjugates thereof GLYKOS FINLAND OY (FI) 2021-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10973920-B2 Saccharide derivative of a toxic payload and antibody conjugates thereof FUT5, STT3A, CD44 ABCB1 332/4885TPSAB1 1260/4885PRSS1 2538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.